Marketing: Page 15
-
Anthem joins insurer-backed generics effort CivicaScript
The subsidiary of hospital-owned nonprofit CivicaRx plans to make six to 10 common generic drugs that don't have enough competition to drive down cost.
By Rebecca Pifer • June 16, 2021 -
Getty Images
Sponsored by 81qdClinical leadership: A foundational double attack strategy
We define the most influential clinicians as Clinical Leaders, those who measurably impact the clinical behavior of other clinicians in their "clinical networks."
June 14, 2021 -
Explore the Trendline➔
Brian Tucker / BioPharma Dive/BioPharma Dive
TrendlineCommercialization
New drugs for obesity and Alzheimer’s look set to become blockbusters, reshaping pharma marketing strategies just as many current top-sellers near looming patent cliffs.
By BioPharma Dive staff -
Permission granted by Biogen
Deep Dive // New Alzheimer's drugsA first-of-its-kind Alzheimer's drug raises heavy questions around who will and won't get it
Biogen priced its newly approved medicine Aduhelm at an average cost of $56,000 a year, adding affordability to other barriers patients may face.
By Jacob Bell • June 8, 2021 -
Permission granted by IQVIA
Sponsored by IQVIAMoving pharma marketing from multichannel to omnichannel
IQVIA experts weigh in on the importance of an omnichannel approach.
June 7, 2021 -
Getty Images: Edited by BioPharma Dive
FDA restricts use of Intercept drug due to liver injury risk
An investigation linked the drug to severe injuries in about two dozen patients, leading the agency to add a new contraindication to the label.
By Kristin Jensen • May 27, 2021 -
ICER, vocal critic of drug company pricing, turns scrutiny to insurers
The watchdog group plans to examine how cost sharing can hurt access to care, but it won't assess some of the most controversial insurer practices.
By Jonathan Gardner • May 25, 2021 -
Sean Gallup via Getty Images
Pfizer, BioNTech to send EU up to 1.8B coronavirus vaccine doses
The deal, which the companies and the bloc have been negotiating for weeks, will significantly expand on the current contract for 600 million shots.
By Kristin Jensen • May 20, 2021 -
Win McNamee via Getty Images
Humira patents take center stage as House panel targets AbbVie pricing
CEO Richard Gonzalez defended the company's practices, arguing its profits help spur innovation: "The products that are on the market today pay for the products of the future," he said.
By Jonathan Gardner • May 18, 2021 -
Getty Images
Sponsored by IQVIATop customer engagement trends in pharma
The future of provider and patient engagement in healthcare.
May 17, 2021 -
Getty Images
Sponsored by FedEx Office6 tips to deliver information that matters using print communications
As remote work continues, print is as important as ever for biopharmaceutical companies when it comes to reaching a varied audience that may include patients, doctors' offices, researchers, and internal staff.
May 17, 2021 -
Kevin C. Cox via Getty Images
CDC panel endorses Pfizer vaccine for 12- to 15-year-olds
The vote, which the CDC officially adopted hours after, gives a clear green light for states to begin vaccinating younger adolescents with the shot.
By Ned Pagliarulo • Updated May 13, 2021 -
Amgen asks FDA for approval of key asthma drug
Tezepelumab is one of Amgen's top experimental medicines and a U.S. OK would help its efforts to offset revenue declines from its aging blockbusters.
By Ned Pagliarulo • May 10, 2021 -
Jon Cherry via Getty Images
FDA, CDC support resuming use of J&J vaccine after advisory panel vote
While health officials have documented more cases of a rare blood clotting syndrome associated with J&J's vaccine, a CDC committee supported use of the shot with an added warning.
By Ned Pagliarulo , Ben Fidler • Updated April 23, 2021 -
Shutterstock
Sponsored by Veeva CrossixA year with COVID-19: The impact of data on pharma marketing
Learn how three pharma brands used data to validate and adjust their promotional spend in 2020.
March 29, 2021 -
Courtesy of Walmart
Biden administration hikes Medicare reimbursement for coronavirus vaccines
The increased payout by Medicare is intended to speed up distribution of the three currently available shots.
By Shannon Muchmore • March 16, 2021 -
The 5th
Sponsored by FylloThe essential audience for well-being
For marketers in the health space, cannabis and CBD consumers represent an audience that is in search of both alternative and conventional methods of well-being as their transformation from patient to participant accelerates.
March 1, 2021 -
Courtesy of Novavax
Novavax broadens reach of global coronavirus vaccine alliance with new deal
As more transmissible variants spread across the globe, there's growing urgency to equitably allocate vaccine supplies. A deal between Novavax and COVAX will significantly bolster that effort.
By Ben Fidler • Feb. 19, 2021 -
Permission granted by IQVIA
Sponsored by IQVIAPersonalize your omnichannel marketing today and see the benefits tomorrow
With virtual interactions here to stay, it's important that pharma marketers continue to embrace the digital world. Learn how a personalized, insights-led approach to marketing drives results.
Jan. 19, 2021 -
Courtesy of BioNTech
Pfizer, BioNTech win EU vaccine approval as UK grapples with new coronavirus variant
In a press conference on the authorization, BioNTech CEO Ugur Sahin expressed confidence the vaccine would protect against the emerging virus variant in the U.K.
By Ned Pagliarulo • Dec. 22, 2020 -
Permission granted by IQVIA Brand World
Sponsored by IQVIAThe role of optimized omnichannel marketing in a challenging environment
How can pharma marketers overcome today's cost-constrained, competitive environment?
Dec. 18, 2020 -
Permission granted by BioNTech SE
Hospitals start coronavirus vaccinations in sweeping, nationwide effort
A New York nurse was among the first to get the shot after FDA authorization last week. Many other health systems are either preparing to receive supplies or are already beginning immunizations.
By Samantha Liss • Dec. 14, 2020 -
Permission granted by University of Maryland School of Medicine
UK drug regulator is first to clear Pfizer, BioNTech's coronavirus vaccine
The approval is a notable milestone in the historic pursuit of a protective shot for COVID-19. The two drugmakers plan to ship the first doses within days.
By Jonathan Gardner • Dec. 2, 2020 -
Permission granted by BioNTech SE
CDC panel recommends giving first coronavirus vaccines to healthcare workers, nursing home residents
Advisers on the CDC panel cited risk and disease burden as reasons for setting their priority list for the first vaccine doses to become available, supply of which will be extremely limited.
By Jonathan Gardner • Dec. 1, 2020 -
Permission granted by BioNTech SE
Hospitals scramble to get ready for coronavirus vaccines
Facilities are preparing ultra-cold storage capabilities and reviewing security plans as they brace for their role in distributing potentially multiple shots.
By Shannon Muchmore • Nov. 19, 2020 -
As US cases surge, FDA clears first fully at-home COVID-19 test
The prescription test from Lucira Health can deliver results within 30 minutes, and could help boost U.S. testing capacity. Some experts, however, called for more guidance on proper use.
By Greg Slabodkin • Nov. 18, 2020
Previous
